vTv Therapeutics (VTVT) Return on Capital Employed Growth (3y) (2018 - 2026)
vTv Therapeutics (VTVT) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,782.00 |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | 10,090.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,090.00 |
| Dec 31, 2025 | 4,726.00 |
| Sep 30, 2025 | 3,840.00 |
| Jun 30, 2025 | 1,675.00 |
| Mar 31, 2025 | 15,431.00 |
| Dec 31, 2024 | 4,047.00 |
| Sep 30, 2024 | -2,104.00 |
| Jun 30, 2024 | 1,760.00 |
| Mar 31, 2024 | -1,068.00 |
| Dec 31, 2023 | -82,249.00 |
| Sep 30, 2023 | 338,673.00 |
| Jun 30, 2023 | -111,017.00 |
| Mar 31, 2023 | -74,270.00 |
| Dec 31, 2022 | -58,349.00 |
| Sep 30, 2022 | -37,175.00 |
| Jun 30, 2022 | -27,378.00 |
| Mar 31, 2022 | -45,386.00 |
| Dec 31, 2021 | -32,850.00 |
| Sep 30, 2021 | -26,932.00 |
| Jun 30, 2021 | -29,890.00 |